WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE. WebSep 1, 2024 · Following shareholder approval, Bio-Techne's Board of Directors intends to declare the stock split and set a record date and distribution date for the stock dividend. The stock dividend is expected to occur in the Company's second quarter of …
BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK …
WebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell ... WebApr 8, 2024 · The reverse stock split is necessary to price an IPO in the $13-$17 price range typical of early stage biotech IPOs. The initial S-1 filed with the Securities and Exchange Commission (SEC) discloses all share amounts pre-split. After the IPO roadshow, the board and underwriters will get together and recommend a stock price … philko chem logistics inc
BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, …
WebBio-Techne (TECH) has 3 splits in our Bio-Techne stock split history database. The first split for TECH took place on November 18, 1997. This was a 2 for 1 split, meaning for each … WebApr 14, 2024 · National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Get Rating) by 3,001.3% in the 4th quarter, according to its most … WebApr 10, 2024 · 9 brokerages have issued 1 year target prices for Bio-Techne's shares. Their TECH share price forecasts range from $88.00 to $120.00. On average, they anticipate the company's stock price to … phil knutson city of becker mn